Neuronetics Inc. (NASDAQ: STIM)
$2.00
+0.1100 ( +5.82% ) 190.5K
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
Market Data
Open
$2.00
Previous close
$1.89
Volume
190.5K
Market cap
$60.00M
Day range
$1.89 - $2.04
52 week range
$1.03 - $5.07
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 6 | Apr 11, 2024 |
8-k | 8K-related | 13 | Mar 28, 2024 |
8-k | 8K-related | 13 | Mar 25, 2024 |
10-k | Annual reports | 117 | Mar 08, 2024 |
8-k | 8K-related | 14 | Mar 06, 2024 |
8-k | 8K-related | 14 | Mar 05, 2024 |
8-k | 8K-related | 16 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 01, 2024 |
4 | Insider transactions | 1 | Mar 01, 2024 |
4 | Insider transactions | 1 | Feb 29, 2024 |